GSK3B and acute myeloid leukemia: Overall, our findings indicate the NUC-7738 inhibits β-catenin signalling through GSK3β-mediated degradation of β-catenin, inhibition of β-catenin target genes and reduction in the self-renewal of AML cells resulting in eventual apoptosis.